Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy

Nearly 500’000 fatalities due to COVID-19 have been reported globally and the death toll is still rising. Most deaths are due to acute respiratory distress syndrome (ARDS), as a result of an excessive immune response and a cytokine storm elicited by severe SARS-CoV-2 lung infection, rather than by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Berishvili, Ekaterine, Kaiser, Laurent, Cohen, Marie, Berney, Thierry, Scholz, Hanne, Floisand, Yngvar, Mattsson, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372209/
https://www.ncbi.nlm.nih.gov/pubmed/32696426
http://dx.doi.org/10.1007/s12015-020-10004-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372209/
https://www.ncbi.nlm.nih.gov/pubmed/32696426
http://dx.doi.org/10.1007/s12015-020-10004-x

Ejemplares similares